background image

Paid Clinical Trials Grand Rapids

Discover 516 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

DAY301

Recruiting
PHASE1

Sponsor:

Day One Biopharmaceuticals, Inc.

Location:

Grand Rapids MI, Indianapolis IN, San Antonio TX

Code:

NCT06752681

Conditions

Advanced or Metastatic Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DAY301

Pegozafermin

Recruiting
PHASE3

Sponsor:

89bio, Inc.

Location:

Wyoming MI, Ann Arbor MI, Ypsilanti MI, Chicago ILshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Medtronic

Recruiting

Sponsor:

Medtronic Cardiac Surgery

Location:

Grand Rapids MI, Toledo OH, Indianapolis IN, Pittsburgh PAshow 10 more

Code:

NCT03546374

Conditions

Persistent Atrial Fibrillation

Longstanding Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Ablation

Cardioblate and Cryoflex hand held devices

Chemotherapy with Endocrine Therapy

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Grand Rapids MI, Wyoming MI, Norton Shores MI, Muskegon MIshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & Daratumumab

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Grand Rapids MI, Wyoming MI, Norton Shores MI, Muskegon MIshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Selumetinib vs. Carboplatin/Vincristine

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Grand Rapids MI, Ann Arbor MI, Milwaukee WI, Chicago ILshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Milvexian

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Lansing MI, Jackson MI, Elkhart IN, Flint MIshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Nivolumab, Ipilimumab, Cabozantinib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Lansing MI, Jackson MI, Saginaw MI, Chelsea MIshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

Saruparib

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Grand Rapids MI, Glenview IL, Fort Wayne IN, Troy MIshow 115 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Odronextamab & Cemiplimab

Recruiting
PHASE1

Sponsor:

Regeneron Pharmaceuticals

Location:

Grand Rapids MI, Cleveland OH, Baltimore MD, Philadelphia PAshow 5 more

Code:

NCT02651662

Conditions

Relapsed/Refractory Aggressive B-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemiplimab

odronextamab